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Copyright © 2011 JCBN 2011 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. This study was to assess the resting energy expenditure of patients
with esophageal cancer using indirect calorimetry. Eight male
patients with esophageal cancer and eight male healthy controls
were enrolled in this study. All patients underwent transthoracic
esophagectomy with lymph nodes dissections. The resting energy
expenditure was measured preoperatively, and on postoperative
day 7 and 14 using indirect calorimetry. Preoperatively, the mea 
sured resting energy expenditure/body weight in these patients
was significantly higher than that of the controls (23.3 ± 2.1 kcal/
kg/day vs 20.4 ± 1.6 kcal/kg/day), whereas the measured/predicted
energy expenditure from the Harris Benedict equation ratio was
1.01 ± 0.09, which did not differ significantly from the control
values. The measured resting energy expenditure/body weight
was 27.3 ± 3.5 kcal/kg/day on postoperative day 7, and 23.7 ± 5.07
kcal/kg/day on postoperative day 14. Significant increases in the
measured resting energy expenditure were observed on posto 
perative day 7, and the measured/predicted energy expenditure
ratio was 1.17 ± 0.15. In conclusion, patients with operable
esophageal cancers were almost normometabolic before surgery.
On the other hand, the patients showed a hyper metabolic status
after esophagectomy. We recommended that nutritional manage 
ment based on 33 kcal/body weight/day (calculated by the mea 
sured resting energy expenditure × active factor 1.2–1.3) may be
optimal for patients undergoing esophagectomy.
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Introduction It is believed that the energy expenditure (mREE) is increased
in cancer patients.(1) Typically, the mREE was found to be
elevated in patients with lung or pancreatic cancers.(2) On the
other hand, Dempsey suggested that the largest portion of eso-
phageal cancer patients was normometabolic, whereas patients
with pancreatic and hepatobiliary tumors tended to be hypo-
metabolic, and patients with gastric cancer tended toward hyper-
metabolism.(3) However, it should be noted that malnourished
cancer patients who were losing weight were enrolled in their
studies.
In many patients, weight loss is observed in the terminal stages
of cancer. There is usually a negative energy balance which results
from a decrease in energy intake due to anorexia, and increased
energy expenditure. This rise in energy expenditure is usually
mild (100 to 300 kcal/day), but can cause a loss of body weight.(1)
On the other hand, weight loss is the first symptom that prompts
the patient to seek medical attention. However, it remains unclear
whether the mREE is increased in patients with early stage cancer
or operable cancer. Therefore, we compared the mREE in patients
with operable esophageal cancer to that in healthy controls.
Furthermore, we also performed weekly indirect calorimetry on
patients undergoing esophagectomy because an accurate assess-
ment of their energy needs is required for patients undergoing
surgery to fulfill their energy requirements, and to avoid complica-
tions associated with over feeding.(4,5)
Typically, the energy requirements in parenteral nutrition or
enteral nutrition are determined by the predicted resting energy
expenditure (pREE) calculated by the Harris-Benedict (HB)
equation.(6) The value is multiplied by activity and stress factors to
determine the total energy requirement.(7) Although there have
been several studies reporting that the energy expenditure of
patients undergoing surgery changes to a hyper-metabolic status,
the finding of an increased mREE rate remains controversial.(8–11)
Transthoracic esophagectomy accompanied by lymph nodes (LNs)
dissection is one of the most invasive of all gastrointestinal proce-
dures. Therefore, we evaluated the energy metabolism of patients
undergoing esophagectomy, and determined the optimal energy
requirements for nutritional management.
Subjects and Methods
Patients. Eight male patients and eight healthy controls were
enrolled in this study. Patients with carcinomas of the thoracic
esophagus underwent a right thoracotomy and transthoracic
esophagectomy with LNs dissections. The patients were admitted
to the department of Gastroenterology Unit of the Shiga University
of Medical Science Hospital. The ethics committee of the Shiga
University of Medical Science approved this study. Staging of the
carcinomas after surgery indicated that one patient had stage I, two
had stage II, four had stage III, and one had stage IV a tumors.
The patients were given 750 kcal/day of liquid diet supple-
mented with arginine, n-3 fatty acids, and RNA (IMPACT;
Ajinomoto Pharma, Tokyo, Japan) in addition to a conventional
diet for 5 days before the operation. The patients received 35 kcal/
body weight (BW)/day as the daily amount of IMPACT plus a
conventional diet.
All patients who underwent esophagectomy also received a
jejunostomy. Parenteral nutrition and enteral nutrition were com-
menced on postoperative day (POD) 2. Oral intake was initiated
on POD7. The daily energy requirements were calculated by the




tomy without major complications.
Indirect calorimetry (IC). The mREEs and respiratory
quotients (RQ) were measured preoperatively with the patients
lying at rest and on POD7 and POD14. A computed open-circuit
indirect calorimeter (AE-300S; Minato Medical Science Co.,
Osaka, Japan)(12,13) was used for the mREEs and RQ determina-
tions. The measurements were performed in the morning after an
overnight fast. However, the infusion of parenteral nutrition was
maintained in these patients.
The mREE was calculated from the oxygen consumption (VO2)
and carbon dioxide production (VCO2) by the abbreviated Weir
equation(14):
mREE = (3.94 × VO2 +1 . 1 1× VCO2) × 1.44
The measurement of the non protein RQ was calculated as
RQ = VCO2/VO2. The mREEs were compared with the pREE
calculated by the HB equation based on current body weight.(6)
pREE = 66.47 + 13.75 × W + 5.0 × H – 6.75 × A
where W is the weight in kg, H is the height in cm, and A is the age
in years.
Statistical analysis. Differences between the groups were
analyzed with the Kruskal-Wallis test. Correlations were investi-
gated with Spearman rank correlation tests, and a p value <0.05
was considered to be statistically significant.
Results
Nutritional status of patients with esophageal cancer.
Table 1 shows the preoperative nutritional parameters of the eight
male patients. The mean ± SD of the total protein (TP), serum
albumin (Alb), total lymphocyte counts (TCL), and total cholesterol
(T-chol) levels were 6.2 ± 0.5 g/dl, 3.6 ± 0.3 g/dl, 1248.7 ± 540.7/
mm3, and 182.4 ± 20.3 mg/dl, respectively. The mean prealbumin
(PA), retinol-binding protein (RBP), and C-reactive protein (CRP)
levels were 28.0 ± 8.9, 3.5 ± 1.1, and 0.45 ± 1.04 mg/dl, respec-
tively.
Comparison of the REE and RQ in healthy controls and
patients. The characteristics of the eight male patients before
surgery and the eight male healthy controls are shown in Table 2.
The mean age of the patients and controls did not differ signifi-
cantly. In comparison with the healthy controls, the mean BW,
body mass index (BMI), and pREE were significantly lower in the
cancer patients.
The mREE in patients before surgery measured by IC was
1257.0 ± 109.9 kcal/day, and the pREE in these patients was
1256.0 ± 148.7 kcal/day. The mREE/pREE ratio in the patients
before surgery was 1.01 ± 0.09, and there was a positive correla-
tion between the pREE and mREE (p<0.05).
The mREE of the healthy controls was 1438.3 ± 204.3 kcal/day.
Although no significant difference was noted between the mean
mREE of the patients and the healthy controls, the mean mREE/
BW of the patients before surgery was significantly higher than
that of the controls (23.3 ± 2.1 kcal/kg/day vs 20.4 ± 1.6 kcal/kg/
day) (Fig. 1a). The mREE/pREE ratio in the patients before surgery
did not differ significantly from that in the controls (Fig. 1b).
The RQ of the patients was almost the same as that of the
controls (Fig. 2).
Changes in the REE and RQ of the patients during the
perioperative period. The mREE/BW on POD7 (27.3 ± 3.5
kcal/kg/day) was significantly higher than the preoperative value.
Thereafter, the mREE/BW on POD14 was almost the same as the
preoperative period (Fig. 3a). The mean mREE/pREE was 1.17 ±
0.15 on POD7 and 1.05 ± 0.22 on POD14. (Fig. 3b). No statisti-
cally significant differences were observed in the RQ during the
perioperative period (Fig. 4).
The mean energy requirements calculated by the mREEs ×
active factor 1.2–1.3 on POD7 and POD14 were 32.8 kcal/kg/day
and 30.8 kcal/kg/day, respectively. As shown in Fig. 5, the mean
nutritional intakes on POD7 and POD14, as percentages of the
requirements, were 101.8% and 98.7% for energy, respectively.
The oral intakes, as percentages of the requirements, were only
14.2% and 27.2% for energy, respectively.
Discussion
In this study, we showed that patients with operable esophageal
cancers were almost normometabolic before surgery. However,
we also demonstrated that the resting energy expenditure was
significantly increased after surgery in patients undergoing a
transthoracic esophagectomy with LNs dissections. In this study,
we assessed the mREE and pREE in only male patients, because
no female patients underwent transthoracic esophagectomies
Table 1. Baseline characteristics of patients with operable esophageal
cancer






TP (g/dl) 6.2 ± 0.5
Alb (g/dl) 3.6 ± 0.3
TLC (/mm3) 1248.7 ± 540.7
T chol (mg/dl) 182.4 ± 20.3
CRP (mg/dl) 0.45 ± 1.04
PA (mg/dl) 28.0 ± 8.9
RBP (mg/dl) 3.5 ± 1.1
Table 2. Background of the patients and healthy controls
BMI, Body mass index. Values are mean ± SD or total number of patients.
Controls Patients p value
Patient number 8 8 —
Male / Female 8/0 8/0 —
Age (y) 58.0 ± 19.3 58.4 ± 4.3 0.96
Height (cm) 169.1 ± 5.7 167.4 ± 7.3 0.62
Body weight (kg) 70.7 ± 8.0 54.3 ± 7.1 <0.001
BMI (kg/m2) 24.7 ± 1.7 19.3 ± 1.9 <0.001
pREE (kcal/day) 1497.3 ± 222.4 1256.0 ± 148.7 0.02
mREE (kcal/day) 1438.3 ± 204.3 1257.0 ± 109.9 0.06 J. Clin. Biochem. Nutr. | November 2011 | vol. 49 | no. 3 | 171
©2011 JCBN
H. Okamoto et al.
during this study period.
Previous studies have suggested that the mREE may be elevated
in patients with several types of tumors, such as lung and pancreatic
cancers. However, the findings regarding gastrointestinal malig-
nancy are controversial.(2,15,16) Dempsey compared the mREE to the
pREE from the HB equation based on current BW, and suggested
that most esophageal cancer patients were normometabolic. One
third of their patients had liver metastases, and more than half of
their patients had received TPN at the time of study.(3) However,
few studies have reported the mREE in patients with early stages
of cancer or operable cancer. This is the first report to assess the
mREE in patients with operable esophageal cancers and compare
it to healthy controls. We showed that the mREE measured by IC
in patients with esophageal cancer was almost the same as the
pREE, but it was significantly greater than that in the controls
when expressed in relation to the BW. The higher mREE/BW of
the patients was reflected in a significant reduction in their BMI
when compared to the controls.
Weight loss is a common clinical finding in patients with cancer.
Weight loss in cancer patients is frequently ascribed to a combina-
tion of reduced food intake and hypermetabolism. Recently, the
mediators of anorexia and metabolic change in cancer patients
have been postulated to include proinflammatory cytokines,
neuroendocrine stress hormones and tumor-specific cachectic
factors such as proteolysis-inducing factor (PIF).(2) However, the
levels of serum albumin, prealbumin, retinol-binding protein, and
C-reactive protein were within the normal range in our patients
prior to surgery. In addition, all patients maintained adequate
oral nutrition. These data implied that although weight loss is
commonly associated with the terminal stages of cancer, weight
loss also occurs in operable cancers, and weight loss is not
exclusively caused by the mREE or food intake.
The pREE calculated by the HB equation has been widely
used to evaluate the energy status of patients.(6) The total energy
requirement is calculated by the pREE × activity factor × stress
factor.(7,17) Theoretically, the pREE is expected to equal the mREE
in healthy humans, and the mREE/pREE ratio is a marker for a
hyper-metabolic status.(12,13,17)
The increased rates of mREE in patients undergoing abdominal
surgery are controversial. Previously, it has been reported that the
REE was significantly increased after abdominal surgery, and that
TPN therapy consisting of 45 kcal/kg/day was optimal for these
patients. This means that measurements of the energy requirement
can be calculated by the pREE × 1.75. Rutten et al.(9) also reported
that the pREE × 1.75–2.0 kcal/day should be optimal for TPN in
patients undergoing major surgery. On the other hand, Federix
et al.(10) showed a 10% increase in the mREE of patients under-
going gastrointestinal surgery without major complications.
An esophagectomy is one of the most invasive gastrointestinal
procedures. Sato et al.(18,19) showed a 31% increase in the mREE in
patients undergoing an esophagectomy. However, the increased rate
in the mREE in our patients was lower than that from previous
studies. The mREE of our patients had increased by 12% to
27.3 ± 3.5 kcal/kg/day after the esophagectomy. The mREE/pREE
ratio, which reflects a stress factor, was elevated to 1.17 on POD7,
and decreased to the preoperative level on POD14. Our results
suggested that the stress factor for esophageal cancer surgery
without major complications should be 1.2 through POD7. Similar
results were obtained from our recent study, which found that
patients who had undergone a pylorus preserving pancreaticoduo-
denostomy (PPPD) showed stress factors of 1.2.(20) Although one
Fig. 1. Measured resting energy expenditure (mREE)/body weight (BW) in patients with esophageal cancer and healthy controls. (a) The mREE/BW
of the patients was significantly higher than that of the healthy controls. Values represent means ± SD. *p<0.05 compared with healthy controls. (b)
Measured resting energy expenditure (mREE)/predicted resting energy expenditure (pREE) in patients with esophageal cancer and healthy controls.
There were no significant differences between the mREE/pREE of patients and healthy controls. Values represent means ± SD.
Fig. 2. Respiratory quotients (RQ) in patients with esophageal cancer
during the preoperative period. There were no significant differences
between the RQ of the patients and healthy controls. Values represent
means ± SD.doi: 10.3164/jcbn.11 13
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would be more likely to find stress-induced hypermetabolism on
earlier postoperative days, the increase in the mREE of patients
undergoing a transhiatal or transthoracic esophagectomy was
almost the same as during the first seven days.(18)
Recently, perioperative management has been dramatically
improved, with the goal of preventing infection, which causes
hyper-metabolism in patients undergoing major surgery. Although
all operations were performed by a single surgeon using the same
surgical procedures in this study, it is possible that the magnitude
of the surgical stress depends on the surgical technique of each
surgeon. Thus, a stress factor of 1.2 in our patients may reflect the
magnitude of the surgical stress induced by the esophagectomy.
The measurement of the energy requirement is very critical for
nutritional management in patients undergoing major surgery such
as pancreatic or esophageal cancers, because over feeding has
been shown to be associated with some clinical complications.(4,5)
In this study, a significant change in the RQ after esophagectomy
was not observed. In previous reports, the RQ was reduced in
patients after a liver resection.(21) This means that the energy
substrate of the remnant liver is principally fatty acids rather than
glucose after a liver resection. In patients undergoing an esopha-
gectomy, however, glucose is mainly utilized after the surgery, as
well as in patients undergoing PPPD.(20,22,23)
Recent studies suggest that specific nutritional compounds,
including arginine, glutamine, n-3 fatty acids, and RNA have been
identified as immunonutrition.(24,25) The ESPEN and SCCM/
ASPEN guidelines support the use of immune enhancing diets in
elective surgery patients during the preoperative period.(26,27)
Immunonutrition has also been shown to be beneficial in subsets
Fig. 3. (a) Changes in the measured resting energy expenditure (mREE) of patients undergoing esophagectomy for esophageal carcinoma. The
mREE of the patients was significantly increased on postoperative day 7. Values represent means ± SD. *p<0.05 compared with preoperative values.
(b) Changes in the measured resting energy expenditure (mREE)/predicted resting energy expenditure (pREE) ratio of patients undergoing
esophagectomy. The mREE/pREE ratio was significantly increased on postoperative day 7. Values represent means ± SD. *p<0.05 compared with
preoperative values.
Fig. 4. Changes in the respiratory quotients (RQ) in patients undergoing
esophagectomy. There were no significant changes in the RQ during
perioperative period. Values represent means ± SD.
Fig. 5. Changes in nutritional intake, including enteral nutrition and
parenteral nutrition, as a percentage of the energy requirements of
patients undergoing oesophagectomy. The energy requirements of the
patients were calculated by the mREE × stress factor 1.2–1.3. Values
represent means ± SD. J. Clin. Biochem. Nutr. | November 2011 | vol. 49 | no. 3 | 173
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of Japanese patients undergoing esophagectomy.(28,29) In our study,
the patients were given 750 kcal/day of IMPACT in addition to a
conventional diet for 5 days before the operation, and all patients
maintained oral nutrition satisfactorily. On the other hand, the oral
intake was generally poor during the early postoperative period.
Previous reports had estimated that the mean time required to
achieve what the patients following esophagectomy considered to
be a socially acceptable diet was 6 months.(30,31) In this regard,
enteral nutrition and total parenteral nutrition were useful backups
for patients with poor oral intake after esophagectomy. The oral
intake must be closely monitored to give sufficient calories to
meet the estimated nutritional requirements.
In summary, patients with operable esophageal cancers were
normometabolic as compared to healthy controls. The mREE of
these patients was significantly increased after an esophagectomy.
The mREE/pREE ratio was increased to 1.17 on POD7, but
decreased to the preoperative level on POD14. Our results
suggest that the daily energy requirements for patients undergoing
esophagectomy are 31–33 kcal/BW/day (calculated by the mREE ×
activity factor 1.2–1.3), and that alternative nutritional therapies
are needed to give sufficient calories to meet the daily energy
requirements.
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